Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...

Indivior (INDV) announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the ...

The first platform trial for amyotrophic lateral sclerosis (ALS), which individually evaluated four experimental drugs, failed to meet key primary endpoints. Still, investigators view the trial as ...

“Can the blind lead the blind? Shall they not both fall into the pit?” Luke 6:39 While “the blind leading the blind” has become an often-used idiom of incompetency and ineffectiveness, the “randomized ...

Vixarelimab led to rapid, dose-dependent reductions in itch severity compared with placebo, with more than 50% decreases in WI-NRS scores at week 16 in the high- and mid-dose groups, and meaningful ...